Anti-UGP2 antibody [EPR10627(B)]

• Supplier: Abcam
• Catalog: ab154817
• Prices: $357.00
• Sizes: 100 µl
• Host: Rabbit
• Clonality: Monoclonal
• Isotype: IgG
• Clone: EPR10627(B)
• Applications: WB IHC-P FC
• Species Reactivities: Mouse, Rat, Human, Pig
• Antigen: A synthetic peptide corresponding to residues within Human UGP2 (Q16851)
• Description: Rabbit Monoclonal
• Gene: UGP2
• Conjugate: Unconjugated

Product images

All lanes : Anti-UGP2 antibody [EPR10627(B)] (ab154817) at 1/1000 dilutionLane 1 : HepG2 cell lysateLane 2 : HeLa cell lysateLane 3 : NIH 3T3 cell lysateLane 4 : Human fetal liver tissue lysateLysates/proteins at 10 µg per lane.

Immunohistochemical analysis of paraffin-embedded Human colon adenocarcinoma labeling UGP2 using ab154817 at 1/50 dilution.

Immunohistochemical analysis of paraffin-embedded Human kidney labeling UGP2 using ab154817 at 1/50 dilution.

Flow cytometric analysis of permeabilized NIH 3T3 cells labeling UGP2 using ab154817 (red) at 1/10 dilution or a rabbit IgG (negative) (green).

Immunohistochemical analysis of paraffin embedded Human skeletal muscle tissue using ab154817 showing +ve staining.

Immunohistochemical analysis of paraffin embedded Human normal liver tissue using ab154817 showing +ve staining.

Immunohistochemical analysis of paraffin embedded Human normal heart tissue using ab154817 showing +ve staining.

Immunohistochemical analysis of paraffin embedded Human normal colon tissue using ab154817 showing +ve staining.

Lanes 1 - 2 : Anti-UGP2 antibody [EPR10627(B)] (ab154817) at 1/10000 dilutionLanes 3 - 4 : Anti-UGP2 antibody [EPR10627(B)] (ab154817) at 1/20000 dilutionLane 5 : Lane 6 : Lane 1 : Pig muscle sarcoplasm tissue lysateLane 2 : Pig muscle sarcoplasm tissue lysateLane 3 : Pig muscle sarcoplasm tissue lysateLane 4 : Pig muscle sarcoplasm tissue lysateLane 5 : Pig muscle sarcoplasm tissue lysateLane 6 : Pig muscle sarcoplasm tissue lysateLysates/proteins at 40 µg per lane.SecondaryHRP-conjugated goat anti-rabbit IgG (H+L) polyclonal at 1/10000 dilutiondeveloped using the ECL techniquePerformed under reducing conditions.